logo
    The measurement of rates of protein turnover, synthesis, and breakdown in man and the effects of nutritional status and surgical injury
    60
    Citation
    14
    Reference
    10
    Related Paper
    Citation Trend
    Keywords:
    Protein turnover
    Protein metabolism
    Nitrogen balance
    Catabolism
    Protein Degradation
    Continual synthesis and breakdown or remodeling of proteins (also called protein turnover) is a principal characteristic of protein metabolism. During animal production, the net differences between synthesis and breakdown represent the actual marketable muscle foods. Because protein synthesis is a highly end-ergonic and protein breakdown is metabolic energy dependent, efficiency of production can be markedly enhanced by lower muscle protein breakdown rates. Herein, various methodological approaches to studying protein breakdown, with particular emphasis toward food-producing animals, are presented. These include whole-animal tracer AA infusions in vivo, quantifying marker AA release from muscle proteins, and in vitro AA release-based methodologies. From such methods, protein synthesis rates and protein breakdown rates (mass units/time) may be obtained. The applications of such methods and innovations based on traditional methods are discussed. Whole-animal in vivo approaches are resource intensive and often not easily applied to high-throughput metabolic screening. Over the last 25 yr, biochemical mechanisms and molecular regulation of protein biosynthesis and protein breakdown have been extensively documented. Proteolysis is dependent in part on the extent of expression of genes for components of cellular proteolytic machinery during skeletal muscle atrophy. It is proposed that high-throughput methods, based on emerging understanding about protein breakdown, may be useful in enhancing production efficiency.
    Protein turnover
    Protein Degradation
    Proteolysis
    Protein metabolism
    Citations (23)
    1. Aspects of nitrogen metabolism in the human neonate were assessed in one full-term infant and six premature infants by means of nitrogen-balance measurements, estimates of obligatory nitrogen losses and determinations of whole-body nitrogen turnover. 2. Our data indicate that the mean protein requirement for maintenance is 1·1 g of protein day−1 kg−1 and that 3·8 g of protein day−1 kg−1 should be sufficient for adequate growth in healthy premature babies. 3. The mean obligatory urinary, faecal and total nitrogen losses were estimated to be 24, 106 and 145 mg day−1 kg−1 respectively. These figures are compared with published values for older infants, and the possible metabolic basis for changes in nitrogen losses during growth and development is discussed. 4. Mean values for whole-body protein synthesis and breakdown were 26·3 ± 7·0 and 23·8 ± 7·4 g of protein day−1 kg−1 respectively. Dietary nitrogen intake accounted for 6–18% of the nitrogen flux through the metabolic pool; urea excretion accounted for 2% of the nitrogen flux. 5. The net protein gain, estimated from nitrogen-balance data, accounted for 9·6% of total daily protein synthesis. 6. These results are discussed in relation to published estimates of whole-body protein synthesis and breakdown at various ages. Their possible significance in the assessment of a ‘maintenance’ requirement for protein and amino acids during the period of rapid growth and development is also considered.
    Nitrogen balance
    Protein turnover
    Protein metabolism
    Nitrogen Cycle
    Urea nitrogen
    Citations (75)
    Adaptation to a low-protein diet (LPD) involves a reduction in the rate of amino acid (AA) flux and oxidation, leading to more efficient use of dietary AA and reduced ureagenesis. Of note, the concept of 'adaptation' to low-protein intakes has been separated from the concept of 'accommodation', the latter term implying a decrease in protein synthesis, with development of wasting, when dietary protein intake becomes inadequate, i.e. beyond the limits of the adaptive mechanisms. Acidosis, insulin resistance and inflammation are recognized mechanisms that can increase protein degradation and can impair the ability to activate an adaptive response when an LPD is prescribed in a chronic kidney disease (CKD) patient. Current evidence shows that, in the short term, clinically stable patients with CKD Stages 3-5 can efficiently adapt their muscle protein turnover to an LPD containing 0.55-0.6 g protein/kg or a supplemented very-low-protein diet (VLPD) by decreasing muscle protein degradation and increasing the efficiency of muscle protein turnover. Recent long-term randomized clinical trials on supplemented VLPDs in patients with CKD have shown a very good safety profile, suggesting that observations shown by short-term studies on muscle protein turnover can be extrapolated to the long-term period.
    Protein turnover
    Protein Degradation
    Low-protein diet
    Protein metabolism
    Catabolism
    Citations (23)
    Early studies have shown that patients with chronic kidney disease (CKD) are able to maintain nitrogen balance despite significantly lower protein intake, but how and to what extent muscle protein metabolism adapts to a low-protein diet (LPD) or to a supplemented very LPD (sVLPD) is still unexplored.We studied muscle protein turnover by the forearm perfusion method associated with the kinetics of 2H-phenylalanine in patients with CKD: (i) in a parallel study in subjects randomized to usual diet (1.1 g protein/kg, n = 5) or LPD (0.55 g protein/kg, n = 6) (Protocol 1); (ii) in a crossover, self-controlled study in subjects on a 0.55 g/kg LPD followed by a sVLPD (0.45 g/kg + amino/ketoacids 0.1 g/kg, n = 6) (Protocol 2).As compared with a 1.1 g/kg containing diet, a 0.55 g/kg LPD induced the following: (i) a 17% to 40% decrease in muscle protein degradation and net protein balance, respectively, (ii) no change in muscle protein synthesis, (iii) a slight (by approximately 7%, P < 0.06) decrease in whole-body protein degradation, and (iv) an increase in the efficiency of muscle protein turnover. As compared with an LPD, an sVLPD induced the following: (i) no change in muscle protein degradation, and (ii) an approximately 50% decrease in the negative net protein balance, and an increase in the efficiency of muscle protein turnover.The results of these studies indicate that in patients with CKD the adaptation of muscle protein metabolism to restrained protein intake can be obtained via combined responses of protein degradation and the efficiency of recycling of amino acids deriving from protein breakdown.
    Protein turnover
    Protein metabolism
    Protein Degradation
    Muscle protein
    Nitrogen balance
    Low-protein diet
    Crossover study
    Citations (34)
    Abstract Background Treatment with glucocorticosteroids causes a negative nitrogen balance, but the kinetic mechanisms responsible for this catabolic effect are controversial. We investigated the effects of 60 mg day −1 prednisolone on protein synthesis and degradation in human skeletal muscle. Materials and methods Healthy adults ( n = 9) were studied in the postabsorptive state, before and after 3 days of prednisolone treatment. The L‐[ring 2,6 ‐3 H 5 ]‐phenylalanine tracer technique, concentration and size distribution of the ribosomes, mRNA content of the ubiquitin‐proteasome pathway components in muscle, phenylalanine flux across the leg, and the free amino acid concentrations in skeletal muscle were used to study muscle protein metabolism. Results The concentrations of most amino acids in arterial blood increased after prednisolone. There were also increased effluxes of phenylalanine, asparagine, arginine, alanine, methionine and isoleucine from the leg. The rate of protein degradation, as measured by the appearance rate (Ra) of phenylalanine, increased by 67% ( P = 0·023) which, together with a doubling of the net release of phenylalanine from the leg ( P = 0·007), indicated accelerated protein degradation. The pathway was not identified but there was no significant increase in mRNAs’ encoding components of the ubiquitin‐proteasome pathway. There was a 6% reduction in polyribosomes ( P = 0·007), suggesting a decrease in the capacity for protein synthesis, although there was no measured decrease in the rate of protein synthesis. Conclusions These findings indicate that high doses of prednisolone lead to a sharp increase in net protein catabolism, which depends more on enhanced protein breakdown, and an uncertain effect on protein synthesis. The mechanisms stimulating proteolysis and the pathway stimulated to increase muscle protein degradation should be explored.
    Protein turnover
    Human muscle
    Turnover